Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system
Drug Discoveries & Therapeutics · 2025
DOI: 10.5582/ddt.2025.01043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, 2025. Verfasst von Qian Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Adalimumab, Antibodies, Monoclonal, Humanized, Ustekinumab, Etanercept. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Reproductive Medicine Center, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zitieren
APA
Liu, Q., Wang, Y., Hu, P., & He, P. (2025). Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2025.01043
Vancouver
Liu Q, Wang Y, Hu P, He P. Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system. Drug Discoveries & Therapeutics. 2025. doi:10.5582/ddt.2025.01043
BibTeX
@article{Liu2025,
author = {Liu, Qian and Wang, Yang and Hu, Panwei and He, Peizhi},
title = {Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system},
journal = {Drug Discoveries & Therapeutics},
year = {2025},
doi = {10.5582/ddt.2025.01043}
}
EUVIMED